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Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81A66Purpose: Oxidative posttranslational modiﬁcations of intracellular
proteins can potentially regulate signaling pathways relevant to carti-
lage destruction in arthritis. In this study, oxidation of cysteine residues
to form sulfenic acid (S-sulfenylation) was examined in osteoarthritic
(OA) chondrocytes and investigated in normal chondrocytes as a
mechanism by which fragments of ﬁbronectin (FN-f) stimulate chon-
drocyte catabolic signaling.
Methods: Chondrocytes isolated from normal and osteoarthritic human
articular cartilage were analyzed using analogs of dimedone which
speciﬁcally and irreversibly react with protein S-sulfenylated cysteines.
Global S-sulfenylation was measured in cell lysates with and without
FN-f stimulation by immunoblotting and in ﬁxed cells by confocal
microscopy. S-sulfenylation in speciﬁc proteins was identiﬁed by mass
spectroscopy and conﬁrmed by immunoblotting. Src activity was
measured in live cells using a FRET biosensor.
Results: Proteins in chondrocytes isolated from osteoarthritic car-
tilage were found to have elevated basal levels of S-sulfenylation
relative to those of chondrocytes from normal cartilage (Figure 1).
Treatment of normal chondrocytes with FN-f induced increased
levels of S-sulfenylation in the following proteins: Ubiquitin-con-
jugating enzyme E2 S (FN-f/control: 2.43), Proto-oncogene tyrosine
kinase Src (FN-f/control: 2.09), and Calpastatin (FN-f/control: 1.91).
FN-f treatment also increased levels of Src activity (Figure 2A). Pre-
treatment with dimedone to alter S-sulfenylation function or with
Src kinase inhibitors inhibited FN-f induced MMP-13 production
(Figure 2B).
Conclusions: These results demonstrate for the ﬁrst time the presence
of oxidative post-translational modiﬁcation of proteins in human
articular chondrocytes by S-sulfenylation. Due to the ability to regulate
the activity of a number of cell signaling pathways, including catabolic
mediators induced by ﬁbronectin fragments, S-sulfenylation may con-
tribute to cartilage destruction in osteoarthritis and deserves further
investigation.
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Purpose: In addition to mechanical damage at the time of joint injury,
the inﬂammatory response which leads to elevated levels of pro-Figure 1. Peak intensities for peptides of aggrecan G2,G3 and C-terminal
propeptide of Collagen IIA in the medium (left) and expiant (right) sam-
ples. Values are means þ/- standard deviation of two technical replicates
for one explant.inﬂammatory cytokines in the synovial ﬂuid has also been reported to
contribute to the progression to osteoarthritis after injury. In this
exploratory study, we used a multiple reaction monitoring proteomics
approach to follow the progression of matrix degradation in response to
mechanical damage and cytokine treatment of human knee cartilage,
and thereby to study potential molecular biomarkers.
Methods: Human cartilage explants (3mm x 1mm) were harvested
from the tibial plateau (Collins Grade 0) of a 19-year old male donor
obtained postmortem through the Gift of Hope Organ and Tissue Donor
Network (Itasca, IL). All procedures were approved by both Rush Uni-
versity and MIT. Groups of 4 explants were treated (individually) with
either cytokines alone (cyt) (100ng/mL TNFa, 50ng/mL IL-6, 250ng/mL
sIL-6R), a single compressive mechanical injury (inj, radially uncon-
ﬁned; 60% strain; 300%/s strain rate), cytokinesþinjury (cytþinj), or not
treated (control), and cultured in serum-free DMEM (supplemented
with ITS) for 21 days. Medium changes were carried out every 3 days;
used medium was collected and stored at -80C for analysis. Cartilage
explants were ﬂash-frozen at the end of the 21 day culture. LC/MS/MS
was performed for all medium and explant samples for the identi-
ﬁcation and targeted quantiﬁcation of peptides by multiple reaction
monitoring (MRM). In the scheduled MRM approach, instrument
parameters were optimized to achieve highest sensitivity for selected
peptides and their transitions (determined using synthetic peptides).
Skyline software was used to identify peptides and quantify peak
intensities.
Results: 170 peptides belonging to 58 proteins were identiﬁed. The
peak intensity is deﬁned as the summed area under the curve of mul-
tiple transitions of the same precursor peptide. Data shown are the
representative results from one explant per condition (similar results
were obtained with at least 3/4 explants) and the values are the aver-
aged peak intensities of two technical replicates. Among the three
peptides that were identiﬁed for aggrecan, peptides in the G2 and G3
domain showed the highest release into medium upon treatment with
cyt and cytþinj (Fig. 1). Collagen II C-propeptides (Fig 1), markers of
collagen biosynthesis, were only found in the medium and explant
samples under control conditions. COMP neo epitope Ser77 was found
to be most abundant in the medium of cytokine-treated explants, with
the highest amount detected on day 21 of treatment (Fig. 2). The same
COMP neo epitope was previously detected in the synovial ﬂuid (SF) of
patients with acute knee trauma. In addition, two other COMP neo
epitopes (N194 and F577) which were found in the SF of OA patients,
were found at elevated levels in the medium of cyt and cytþinj treated
explants. Several additional ECM cleave site neo-epitopes (e.g., CO3A1
neo-epitope shown in Fig. 2) have been identiﬁed, also peaking at Day
21.
Conclusions: This proteomics approach allowed us to unambiguously
identify and quantify multiple peptides and proteins in the cartilage
medium and explants upon treatment with þ/-injurious compression
þ/-cytokines, treatments that mimic the earliest events in post-trau-
matic-OA. We could follow different protein domains, e.g. G1/G2/G3 of
aggrecan, by measuring representative peptides of matrix proteins
released into the medium at 7 time points throughout the 21 day cul-
ture period. COMP neo epitopes which were previously identiﬁed in SF
of knee injury/OA patients were also released by these human cartilage
explants in the cyt and cytþinj treatment group. The absence of colla-
gen pro-peptides and elevated levels of speciﬁc COMP and CO3A1 neo-
epitopes after human knee trauma may be relevant as potential bio-
markers for post traumatic OA. This model system thereby enables
study of the kinetics of biomarker identiﬁcation within cartilage and
release to medium.Figure 2. Peak intensities of COMP-neo epitope S77 and CO3A1 neo-epit-
ope G948 in the medium samples. Values are means þ/- standard devia-
tion of two technical replicates for one explant.
